X
EVH icon

Xponance’s Evolent Health EVH Stock Holding History

Xponance’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24K Buy
+10,524
New +$33.4K ﹤0.01% 1668
2024
Q4 		– Sell
-7,584
Closed -$214K – 1452
2024
Q3 		$214K Buy
+7,584
New +$195K ﹤0.01% 1223
2024
Q2 		– Sell
-6,807
Closed -$223K – 1333
2024
Q1 		$223K Buy
6,807
+98
+1% +$3.13K ﹤0.01% 1152
2023
Q4 		$222K Buy
+6,709
New +$190K ﹤0.01% 1127

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Xponance's EVH Position: Q1 2026 in Review

Xponance opened a new position in Evolent Health (EVH) in Q1 2026: 10,524 shares worth $24K. The stake represents ﹤0.01% of the portfolio and ranks #1668 among its holdings. This is a return to the name: Xponance previously reported a position in EVH as recently as Q3 2024.

Xponance first reported a position in EVH in Q4 2023 and has held it in 4 quarters since. The position peaked at $223K in Q1 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Xponance held 10,524 shares of Evolent Health worth $24K as of Q1 2026.
  • Evolent Health was a new Xponance position in Q1 2026.
  • Evolent Health made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1668 holding.
  • Xponance first reported a position in Evolent Health in Q4 2023 and has held it in 4 quarters since.
  • Xponance's Evolent Health position peaked at $223K in Q1 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.